Demonstration of Functional Similarity Comparing Adalimumab to Biosimilar Candidate ABP 501.

被引：0
|
作者：
Born, Teresa [1 ]
Velayudhan, Jyoti [1 ]
Chen, Yuhfung [2 ]
Thomas, Heather [1 ]
Pastula, Christina [1 ]
Maher, Gwen [2 ]
Brown, Ryan [1 ]
机构：
[1] Amgen Inc, Seattle, WA USA
[2] Amgen Inc, Thousand Oaks, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1503
引用
收藏
页码：S661 / S661
页数：1
相关论文
共 50 条
  • [1] Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
    Jyoti Velayudhan
    Yuh-feng Chen
    Amanda Rohrbach
    Christina Pastula
    Gwen Maher
    Heather Thomas
    Ryan Brown
    Teresa L. Born
    BioDrugs, 2016, 30 : 339 - 351
  • [2] Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
    Velayudhan, Jyoti
    Chen, Yuh-feng
    Rohrbach, Amanda
    Pastula, Christina
    Maher, Gwen
    Thomas, Heather
    Brown, Ryan
    Born, Teresa L.
    BIODRUGS, 2016, 30 (04) : 339 - 351
  • [3] Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
    Liu, Jennifer
    Eris, Tamer
    Li, Cynthia
    Cao, Shawn
    Kuhns, Scott
    BIODRUGS, 2016, 30 (04) : 321 - 338
  • [4] Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
    Jennifer Liu
    Tamer Eris
    Cynthia Li
    Shawn Cao
    Scott Kuhns
    BioDrugs, 2016, 30 : 321 - 338
  • [5] DEMONSTRATION OF FUNCTIONAL SIMILARITY OF PROPOSED BIOSIMILAR ABP 798 TO RITUXIMAB
    McBride, H.
    Maher, G.
    Sweet, H.
    Foltz, I.
    Canon, J.
    Kuhns, S.
    HAEMATOLOGICA, 2017, 102 : 741 - 741
  • [6] Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
    Jiang, Yijia
    Arora, Taruna
    Klakamp, Scott
    Davis, Janice
    Chandrasekher, Yasmin A.
    Young, Glen
    Du, Yue
    Yu, Bin
    Miller, Karen J.
    DRUGS IN R&D, 2023, 23 (04) : 377 - 395
  • [7] Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
    Yijia Jiang
    Taruna Arora
    Scott Klakamp
    Janice Davis
    Yasmin A. Chandrasekher
    Glen Young
    Yue Du
    Bin Yu
    Karen J. Miller
    Drugs in R&D, 2023, 23 : 377 - 395
  • [8] ABP 501, a Proposed Biosimilar to Adalimumab: Functional Similarity Adds to the Totality of Evidence in Support for Biosimilarity in All Approved Indications of Use
    McBride, Helen
    Kuhns, Scott
    Born, Teresa L.
    Kaur, Primal
    GASTROENTEROLOGY, 2016, 150 (04) : S383 - S383
  • [9] RELATIONSHIP BETWEEN PHARMACOKINETICS AND ANTI-DRUG ANTIBODY STATUS OF ABP 501, A BIOSIMILAR CANDIDATE TO ADALIMUMAB
    Kaur, P.
    Chow, V.
    Zhang, N.
    Markus, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 714 - 714
  • [10] Pharmacokinetic and Safety Similarity of High- and Low-Concentration Formulations of Adalimumab Biosimilar ABP 501
    Chow, Vincent
    Zhou, Muhan
    Mytych, Daniel
    Colbert, Alexander
    Miller, Mieke Jill
    Wala, Iwona
    Radziszewski, Waldemar
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4266 - 4268
12345